Setback for Moderna in patent dispute with mRNA competitors

Moderna has suffered a setback in a patent battle against their worst competitors in covid vaccines, Biontech and its partner Pfizer.

By Anders Göransson

November 28, 2023 10:31 AM

The European Patent Office, EPO, declared last week that a patent in mRNA technology, owned by Moderna, is invalid. This is reported by Reuters.

Moderna has sued Biontech in Germany and other countries, claiming that the company has copied mRNA technology that Moderna had patented long before covid-19 appeared in 2019.

Moderna has announced that it intends to appeal the decision.

{{ comments.count === 1 ? '1 comment' : comments.count > 1 ? '{0} comments'.replace('{0}', comments.count) : 'Write a comment' }}

By submitting the comment you accept the terms. See terms

Good comment behavior

Keep a good tone in your comments, avoid personal attacks and posts of marketing character. Apply only link on your comment if it is relevant to the debate.

Be aware that the debates are moderated by the portal's editorial team.

The comment has been created.

Your comment will not be visible until you activate it. In a few moments you will receive an email where you must click on a link to activate your comment.